TLDR GLI1 might protect against the start of skin cancer and is not linked to cancer severity.
The study investigated the role of GLI1 in cutaneous squamous cell carcinoma (cSCC) and found that GLI1 expression was low and heterogeneous in cSCC tumor nests, suggesting a minor role of Hedgehog (HH) signaling in cSCC. High expression of EGFR, pS6, Ki67, and SOX9 at the tumor-stromal interface indicated a more aggressive cSCC phenotype linked to EGF/EGFR signaling. EGFR activation inhibited GLI1 expression via the MEK/ERK pathway, which did not affect cell proliferation or migration. Lower GLI1 levels were associated with increased susceptibility to chemically-induced papilloma formation in a mouse model, suggesting a complex role of GLI1 in skin tumorigenesis. The study involved 10 human cSCC biopsy specimens and six cSCC cell lines.
11 citations
,
March 2014 in “Journal of Investigative Dermatology” Genetic mutation and carcinogen treatment are both needed for skin cancer to develop in these specific mice.
15 citations
,
July 2024 in “Current Issues in Molecular Biology” Understanding molecular processes in skin development is key to creating targeted treatments for skin disorders.
426 citations
,
August 2014 in “Nature Medicine” Skin stem cells interacting with their environment is crucial for maintaining and regenerating skin and hair, and understanding this can help develop new treatments for skin and hair disorders.
31 citations
,
October 2019 in “Genes & Diseases” Basal cell carcinomas and squamous cell carcinomas have different gene activity patterns, suggesting unique treatment approaches.
192 citations
,
January 2015 in “Journal of the American Academy of Dermatology” Targeted cancer therapies often cause serious skin problems that need careful management.
36 citations
,
September 2009 in “Journal of Cellular and Molecular Medicine” New treatments targeting skin stem cells show promise for skin repair, anti-aging, and cancer therapy.